NTRBNASDAQHealthcare · Biotechnology

Nutriband Inc.

$3.53+2.32%(+$0.08)

TickerSpark Score

41/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTRB research report →

52-Week Range2% of range

Low $3.40

Current $3.53

High $11.68

Companynutriband.com

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

CEO: Gareth Sheridan
IPO: 2021
Employees: 13
HQ: Orlando, FL, US

Price Chart

-36.85% · this period

Valuation

Market Cap: $42.91M
P/E: -5.21
P/S: 21.07
P/B: 6.42
EV/EBITDA: -4.81
Div Yield: 0.00%

Profitability

Gross Margin: 27.81%
Op Margin: -408.41%
Net Margin: -404.08%
ROE: -118.30%
ROIC: -120.12%

Growth & Income

Revenue: $2.04M · -4.83%
Net Income: $-8,229,632 · 21.50%
EPS: $-2.58 · -160.61%
Op Income: $-8,317,961
FCF YoY: -8.81%

Performance & Tape

52W High: $11.68
52W Low: $3.40
50D MA: $3.84
200D MA: $5.22
Beta: 1.93
Avg Volume: 10.65K

Get TickerSpark's AI analysis on NTRB

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Jan 31, 25	Sheridan Gareth	director, 10 percent owner, officer: Chief Executive Officer	other	0	—
Jan 29, 25	Sheridan Gareth	director, 10 percent owner, officer: Chief Executive Officer	other	29,333	$236.72K
Mar 20, 24	Sheridan Gareth	director, 10 percent owner, officer: Chief Executive Officer	other	97,500	$254.47K
Jan 23, 25	Goodman Gerald	officer: Chief Financial Officer	other	17,667	$129.68K
Mar 19, 24	Goodman Gerald	officer: Chief Financial Officer	other	75,000	$144.75K
Jun 5, 24	Goodman Gerald	officer: Chief Financial Officer	other	60,085	$115.96K
Mar 20, 24	Goodman Gerald	officer: Chief Financial Officer	other	75,000	$177.75K
Jun 6, 24	Goodman Gerald	officer: Chief Financial Officer	other	87,500	$168.88K
Mar 20, 24	MELNIK SERGUEI	director, officer: President and Secretary	other	97,500	$254.47K
Mar 20, 24	Sheridan Gareth	director, 10 percent owner, officer: CEO	other	75,000	$177.75K